:: CLDF ::

1.	Clonorchis sinensis infection remodels chromatin accessibility in hepatocellular carcinoma.
	Yang, Weilong (W);Wei, Caibiao (C);Chen, Junxian (J);Lin, Qiumei (Q);Qin, Yuling (Y);Huang, Taijun (T);Deng, Xueling (X);Li, Mulin Jun (MJ);Tang, Zeli (Z);Fang, Min (M);

2.	Quantitative literature analysis on efficacy and safety of balloon-occluded transarterial chemoembolization for hepatocellular carcinoma.
	Sui, Wei Fan (WF);Duan, Yu Xin (YX);Cai, Ze Feng (ZF);Li, Jian Yun (JY);Fu, Jian Hua (JH);

3.	Effect of 15- or 25-min intermittent Pringle maneuver on early recurrence of hepatocellular carcinoma after hepatectomy: a protocol for a randomized controlled trial.
	Jia, Xuehai (X);Liao, Anque (A);Huang, Yang (Y);Du, Xiangyu (X);Jiang, Li (L);

4.	Identification of key genes and signaling pathways of liver cancer and model construction for prognosis and diagnosis based on bioinformatics analysis.
	Wei, Benzun (B);Zheng, Yao (Y);Yu, Shuaijun (S);Wang, Aiyun (A);Lyu, Xiao (X);

5.	The impact of ultrasound contrast-enhanced fusion virtual navigation technology-guided microwave ablation (MWA) and standard MWA on the local tumor progression of hepatocellular carcinoma with unclear ultrasound images.
	Zhang, Ping (P);Zhou, Qiong (Q);Zeng, Zhiyong (Z);

6.	Drug-drug interactions between epidermal growth factor receptor tyrosine kinase inhibitors and rivaroxaban in vitro and in vivo.
	Wang, Dongxu (D);Wang, Shuanghu (S);Wu, Hualan (H);Geng, Peiwu (P);An, Yang (Y);Zhou, Xiaoyue (X);Du, Minghui (M);Li, Yuwei (Y);Chong, Jia (J);Li, Yingying (Y);Wang, Fang (F);Lu, Zebei (Z);Wang, Yu (Y);Yang, Jiefu (J);Li, Chuanbao (C);Dai, Dapeng (D);Chen, Hao (H);

7.	Real-world treatment outcomes and clinicopathologic and molecular determinants of response to first-line lenvatinib in patients with advanced follicular cell-derived thyroid cancer.
	Ruicci, Kara M (KM);Deng, Yangqing (Y);Xiao, Tian (T);Eskander, Antoine (A);Goldstein, David (D);Mete, Ozgur (O);Mesci, Aruz (A);Lukovic, Jelena (J);Krzyzanowska, Monika K (MK);Barron, Carly C (CC);Ma, Lucy X (LX);

8.	A modified liver retraction method decreases liver dysfunction after laparoscopic gastrectomy.
	Li, Hao-Jie (HJ);Zhou, Lang (L);Zhang, Wei-Han (WH);Liu, Kai (K);Yang, Kun (K);Hu, Jian-Kun (JK);Chen, Xiao-Long (XL);

9.	Correlation analysis of mitochondrial DNA maintenance-related genes with HCC prognosis, tumor mutation burden and tumor microenvironment features.
	Rong, Fan (F);Cheng, Bin (B);Guo, Ling (L);Zeng, Shaobo (S);Xu, Xunliang (X);Meng, Zhongji (Z);

10.	Development and validation of a nomogram for predicting early recurrence in patients undergoing different courses of postoperative adjuvant transarterial chemoembolisation.
	Tan, Hongkun (H);Xu, Yuyan (Y);Zhang, Cheng (C);Zhong, Kaihang (K);Wen, Yaohong (Y);Wang, Chunming (C);Feng, Zhoubin (Z);Feng, Jianan (J);Fu, Shunjun (S);He, Guolin (G);Cai, Lei (L);Pan, Mingxin (M);

11.	Anoikis in hepatocellular carcinoma: genetic alterations and immune microenvironment insights from single-cell and computational analysis.
	Zhou, Bing (B);Zhang, Jialing (J);Guo, Mingfeng (M);

12.	Mesenchymal circulating tumor cells as prognostic markers in HCC Post-Transplantation: Sirolimus as a potential therapeutic Modulator.
	Chen, Jinyan (J);Wang, Rongsen (R);Li, Huigang (H);Sun, Jiancai (J);Zhao, Ruijie (R);Zhuo, Jianyong (J);Lin, Zuyuan (Z);He, Chiyu (C);Chen, Xingzhu (X);Li, Jun (J);Chen, Leyi (L);Yang, Xudong (X);Wei, Xuyong (X);Zheng, Shusen (S);Xu, Xiao (X);Lu, Di (D);

13.

Exploring the Role of Patient Preferences in Hepatocellular Carcinoma Treatment Decisions: A Qualitative Study.

Moon, Andrew M (AM);Richardson, Daniel (D);Lupu, Gabriel V (GV);Evon, Donna M (DM);Sanoff, Hanna K (HK);Carda-Auten, Jessica (J);Teal, Randall (R);Waheed, Myra (M);Basch, Ethan (E);Mauro, David M (DM);Yanagihara, Ted K (TK);Gerber, David A (DA);Shah, Neil D (ND);Fix, Oren K (OK);Shroff, Hersh (H);Triglianos, Tammy (T);Sorah, Jonathan D (JD);Jia, Jingquan (J);Somasundaram, Ashwin (A);Wagner, Lynne I (LI);Kappelman, Michael D (MD);Schooler, Matthew (M);Phillips, Julia R (JR);Ekuban, Hiwot A (HA);Sanderford, Ariel E (AE);Barritt, A Sidney (AS);

14.	Discovery of novel diagnostic biomarkers of hepatocellular carcinoma associated with immune infiltration.
	Liu, Qiang (Q);Zhang, Hua (H);Xiao, Heng (H);Ren, Ao (A);Cai, Ying (Y);Liao, Rui (R);Yu, Huarong (H);Wu, Zhongjun (Z);Huang, Zuotian (Z);

15.	Hepatotoxicity of ICI monotherapy or combination therapy in HCC: A systematic review and meta-analysis.
	Lu, Yuping (Y);Lin, Jing (J);Lu, Yufeng (Y);Lin, Luping (L);Zheng, Shicheng (S);Chen, Yu (Y);Huang, Sha (S);

16.	Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma.
	Finn, R S (RS);Kudo, M (M);Merle, P (P);Meyer, T (T);Qin, S (S);Ikeda, M (M);Xu, R (R);Edeline, J (J);Ryoo, B-Y (BY);Ren, Z (Z);Cheng, A-L (AL);Galle, P R (PR);Kaneko, S (S);Kumada, H (H);Kamble, S (S);Norquist, J M (JM);Mody, K (K);Wang, A (A);Dubrovsky, L (L);Llovet, J M (JM);

17.	Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study.
	Chen, Qi-Feng (QF);Jiang, Xiongying (X);Hu, Yue (Y);Chen, Song (S);Lyu, Ning (N);Zhao, Ming (M);

18.	The role of early MRI in assessing the risk of local tumor progression following irreversible electroporation for hepatocellular carcinoma treatment.
	Pescatori, Lorenzo Carlo (LC);Dessain, Mathilde (M);N'Kontchou, Gisèle (G);Petit, Arthur (A);Diallo, Abou (A);Blaise, Lorraine (L);Rols, Marie-Pierre (MP);Poignard, Clair (C);Nault, Jean-Charles (JC);Ganne-Carrié, Nathalie (N);Nahon, Pierre (P);Sutter, Olivier (O);Seror, Olivier (O);

19.	Transarterial chemoembolization plus apatinib for unresectable hepatocellular carcinoma: a multicenter, randomized, open-label, phase III trial.
	Kan, Xue-Feng (XF);Liang, Bin (B);Zhang, Xiao-Lin (XL);Yu, Lei (L);Luo, Yao-Chang (YC);Zhou, Shi (S);Liu, Rui-Bao (RB);Xu, Guo-Hui (GH);Li, Hai-Liang (HL);Liao, Zheng-Yin (ZY);Xiang, Hua (H);Lu, Wei (W);Xu, Lin-Feng (LF);Ma, Yi-Long (YL);Xia, Xiang-Wen (XW);Qian, Kun (K);Dong, Xiang-Jun (XJ);Xiong, Fu (F);Song, Song-Lin (SL);Zhao, Chang (C);Huang, Ming (M);Zheng, Chuan-Sheng (CS);

20.	Covered Self-Expanding Metal Stents Versus Multiple Plastic Stents in Treating Biliary Strictures Post-Orthotopic Liver Transplantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
	Rocha Fernandes, Ygor (Y);Visconti, Thiago Arantes de Carvalho (TAC);Dall'Agnol, Marcelo Klotz (MK);Ardengh, André Orsini (AO);Veras, Matheus de Oliveira (MO);Valentim, Evellin Souza Dos Santos (ESDS);Lera Dos Santos, Marcos Eduardo (ME);Matuguma, Sergio Eiji (SE);Bernardo, Wanderley Marques (WM);de Moura, Eduardo Guimarães Hourneaux (EGH);

21.	Causal role of immune cells in primary liver cancer: a mendelian randomization study.
	Liu, Jia (J);Zhang, Tongyuan (T);Gao, Yang (Y);Ji, Dong (D);Chen, Lijian (L);

22.	Association of metformin with risk of digestive tract cancers from a drug target mendelian randomization and cell experiments.
	Wang, Yifei (Y);Cao, Xirong (X);Ren, Jie (J);Chen, Rui (R);Zhang, Xing (X);Liu, Chang (C);Jia, Yifan (Y);Lin, Ting (T);

23.	Unraveling the significance of cuproptosis in hepatocellular carcinoma heterogeneity and tumor microenvironment through integrated single-cell sequencing and machine learning approaches.
	Liu, Wang (W);Xia, Liangjing (L);Peng, Yuan (Y);Cao, Qiang (Q);Xu, Ke (K);Luo, Huiyan (H);Peng, Yongjun (Y);Zhang, Yanping (Y);

24.	Accuracy of cross-sectional imaging in predicting tumor viability using the LI-RADS treatment response algorithm after image-guided percutaneous ablation with radiologic-pathologic explant correlation.
	Shenoy-Bhangle, Anuradha S (AS);Malik, M Saad (MS);Ali, Aamir (A);Jiang, Nan Nancy (NN);Andrabi, Syed Yasir (SY);Singal, Amit (A);Curry, Michael P (MP);Catana, Maria-Andreea (MA);Eckhoff, Devin E (DE);Faintuch, Salomao (S);Ahmed, Muneeb (M);Nasser, Imad Ahmad (IA);Sarwar, Ammar (A);

25.	LDHA-mediated YAP lactylation promotes the tumor progression of hepatocellular carcinoma by inducing YAP dephosphorylation and activation.
	Wei, Xiaoyong (X);Zou, Long (L);Huang, Yanqing (Y);Qiu, Chuan (C);Cheng, Guang (G);Chen, Ye (Y);Rao, Jun (J);

Subscribe